BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meixiong J, Vasavda C, Snyder SH, Dong X. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus. Proc Natl Acad Sci U S A. 2019;116:10525-10530. [PMID: 31068464 DOI: 10.1073/pnas.1903316116] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Düll MM, Kremer AE. Treatment of Pruritus Secondary to Liver Disease. Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0713-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
2 Kremoser C. FXR agonists for NASH: How are they different and what difference do they make? J Hepatol 2021;75:12-5. [PMID: 33985820 DOI: 10.1016/j.jhep.2021.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen Y, Wang ZL, Yeo M, Zhang QJ, López-Romero AE, Ding HP, Zhang X, Zeng Q, Morales-Lázaro SL, Moore C, Jin YA, Yang HH, Morstein J, Bortsov A, Krawczyk M, Lammert F, Abdelmalek M, Diehl AM, Milkiewicz P, Kremer AE, Zhang JY, Nackley A, Reeves TE, Ko MC, Ji RR, Rosenbaum T, Liedtke W. Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine. Gastroenterology 2021;161:301-317.e16. [PMID: 33819485 DOI: 10.1053/j.gastro.2021.03.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Caldwell A, Grundy L, Harrington AM, Garcia-Caraballo S, Castro J, Bunnett NW, Brierley SM. TGR5 agonists induce peripheral and central hypersensitivity to bladder distension. Sci Rep 2022;12:9920. [PMID: 35705684 DOI: 10.1038/s41598-022-14195-w] [Reference Citation Analysis]
5 Meixiong J, Dong X, Weng HJ. Neuropathic Itch. Cells 2020;9:E2263. [PMID: 33050211 DOI: 10.3390/cells9102263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Langedijk J, Bolier R, Tolenaars D, Ten Bloemendaal L, Duijst S, de Waart D, Beuers U, Bosma P, Elferink RO. Reduced spontaneous itch in mouse models of cholestasis. Sci Rep 2021;11:6127. [PMID: 33731871 DOI: 10.1038/s41598-021-85660-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sanjel B, Maeng HJ, Shim WS. BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus. Sci Rep 2019;9:10888. [PMID: 31350433 DOI: 10.1038/s41598-019-47267-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
8 Yu H, Wangensteen K, Deng T, Li Y, Luo W. MRGPRX4 in Cholestatic Pruritus. Semin Liver Dis 2021;41:358-67. [PMID: 34161994 DOI: 10.1055/s-0041-1730923] [Reference Citation Analysis]
9 Sanjel B, Shim WS. Recent advances in understanding the molecular mechanisms of cholestatic pruritus: A review. Biochim Biophys Acta Mol Basis Dis 2020;1866:165958. [PMID: 32896605 DOI: 10.1016/j.bbadis.2020.165958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 [DOI: 10.1101/2020.10.26.354654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Ferrell JM, Chiang JY. Bile acid receptors and signaling crosstalk in the liver, gut and brain. Liver Research 2021;5:105-18. [DOI: 10.1016/j.livres.2021.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fiorucci S, Biagioli M, Baldoni M, Ricci P, Sepe V, Zampella A, Distrutti E. The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease. Expert Opin Drug Discov 2021;:1-16. [PMID: 33849361 DOI: 10.1080/17460441.2021.1916465] [Reference Citation Analysis]
13 Langedijk JAGM, Beuers UH, Oude Elferink RPJ. Cholestasis-Associated Pruritus and Its Pruritogens. Front Med (Lausanne) 2021;8:639674. [PMID: 33791327 DOI: 10.3389/fmed.2021.639674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kremer AE, Mayo MJ, Hirschfield G, Levy C, Bowlus CL, Jones DE, Steinberg A, McWherter CA, Choi YJ. Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis. Liver Int 2021. [PMID: 34403559 DOI: 10.1111/liv.15039] [Reference Citation Analysis]
15 Düll MM, Kremer AE. Newer Approaches to the Management of Pruritus in Cholestatic Liver Disease. Curr Hepatology Rep 2020;19:86-95. [DOI: 10.1007/s11901-020-00517-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zaufel A, van de Wiel SMW, Yin L, Fauler G, Chien D, Dong X, Gilmer JF, Truong JK, Dawson PA, van de Graaf SFJ, Fickert P, Moustafa T. Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions. Biochim Biophys Acta Mol Basis Dis 2021;1867:166153. [PMID: 33895309 DOI: 10.1016/j.bbadis.2021.166153] [Reference Citation Analysis]
17 Xiong Z, Zhu X, Geng J, Xu Y, Wu R, Li C, Fan D, Qin X, Du Y, Tian Y, Fan Z. Intestinal Tuft-2 cells exert antimicrobial immunity via sensing bacterial metabolite N-undecanoylglycine. Immunity 2022:S1074-7613(22)00124-8. [PMID: 35320705 DOI: 10.1016/j.immuni.2022.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Atanes P, Ashik T, Persaud SJ. Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation. Pharmacol Ther 2021;228:107928. [PMID: 34174278 DOI: 10.1016/j.pharmthera.2021.107928] [Reference Citation Analysis]
19 Steele HR, Han L. The signaling pathway and polymorphisms of Mrgprs. Neurosci Lett 2021;744:135562. [PMID: 33388356 DOI: 10.1016/j.neulet.2020.135562] [Reference Citation Analysis]
20 Yun Y, Zhang C, Guo S, Liang X, Lan Y, Wang M, Zhuo N, Yin J, Liu H, Gu M, Li J, Xie X, Nan F. Identification of Betulinic Acid Derivatives as Potent TGR5 Agonists with Antidiabetic Effects via Humanized TGR5H88Y Mutant Mice. J Med Chem 2021;64:12181-99. [PMID: 34406006 DOI: 10.1021/acs.jmedchem.1c00851] [Reference Citation Analysis]
21 Mizuno H, Kihara Y. Druggable Lipid GPCRs: Past, Present, and Prospects. Adv Exp Med Biol 2020;1274:223-58. [PMID: 32894513 DOI: 10.1007/978-3-030-50621-6_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zhang Q, Henry G, Chen Y. Emerging Role of Transient Receptor Potential Vanilloid 4 (TRPV4) Ion Channel in Acute and Chronic Itch. Int J Mol Sci 2021;22:7591. [PMID: 34299208 DOI: 10.3390/ijms22147591] [Reference Citation Analysis]
23 Vítek L. Bilirubin as a signaling molecule. Med Res Rev 2020;40:1335-51. [PMID: 32017160 DOI: 10.1002/med.21660] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
24 Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, Hayes BW, Liu J, Gumpper RH, Bender BJ, Slocum ST, Krumm BE, Lansu K, McCorvy JD, Kroeze WK, English JG, DiBerto JF, Olsen RHJ, Huang XP, Zhang S, Liu Y, Kim K, Karpiak J, Jan LY, Abraham SN, Jin J, Shoichet BK, Fay JF, Roth BL. Structure, function and pharmacology of human itch GPCRs. Nature 2021;600:170-5. [PMID: 34789874 DOI: 10.1038/s41586-021-04126-6] [Reference Citation Analysis]
25 He L, Li C, Jiang C, Zhang J, Gu X, Qiu W. Synthesis of Lithocholic Acid from Plant-sourced Bisnoralcohol. Organic Preparations and Procedures International. [DOI: 10.1080/00304948.2022.2057782] [Reference Citation Analysis]
26 Xing Y, Chen J, Hilley H, Steele H, Yang J, Han L. Molecular Signature of Pruriceptive MrgprA3+ Neurons. J Invest Dermatol 2020;140:2041-50. [PMID: 32234460 DOI: 10.1016/j.jid.2020.03.935] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
27 Misery L, Brenaut E, Pierre O, Le Garrec R, Gouin O, Lebonvallet N, Abasq-Thomas C, Talagas M, Le Gall-Ianotto C, Besner-Morin C, Fluhr JW, Leven C. Chronic itch: emerging treatments following new research concepts. Br J Pharmacol 2021. [PMID: 34463358 DOI: 10.1111/bph.15672] [Reference Citation Analysis]
28 Inan S, Torres-Huerta A, Jensen LE, Dun NJ, Cowan A. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. Eur J Pharmacol 2019;864:172702. [PMID: 31568781 DOI: 10.1016/j.ejphar.2019.172702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
29 Palmer CB, Meyrath M, Canals M, Kostenis E, Chevigné A, Szpakowska M. Atypical opioid receptors: unconventional biology and therapeutic opportunities. Pharmacol Ther 2021;:108014. [PMID: 34624426 DOI: 10.1016/j.pharmthera.2021.108014] [Reference Citation Analysis]
30 Yang M, Zhang CY. G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment. World J Gastroenterol 2021; 27(8): 677-691 [PMID: 33716447 DOI: 10.3748/wjg.v27.i8.677] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Inan S, Cowan A. Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans. Handb Exp Pharmacol 2020. [PMID: 33296031 DOI: 10.1007/164_2020_420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Kremer AE. What are new treatment concepts in systemic itch? Exp Dermatol 2019;28:1485-92. [DOI: 10.1111/exd.14024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
33 Gurnani P, Miloh T, Chandar J, Landau DA, Hajjar F, Yosipovitch G. Systemic causes of non-dermatologic chronic pruritus in the pediatric population and their management: An unexplored area. Pediatr Dermatol 2021;38:1051-60. [PMID: 34515372 DOI: 10.1111/pde.14596] [Reference Citation Analysis]
34 Steele HR, Xing Y, Zhu Y, Hilley HB, Lawson K, Nho Y, Niehoff T, Han L. MrgprC11+ sensory neurons mediate glabrous skin itch. Proc Natl Acad Sci U S A 2021;118:e2022874118. [PMID: 33876765 DOI: 10.1073/pnas.2022874118] [Reference Citation Analysis]
35 Szöllősi AG, Oláh A, Lisztes E, Griger Z, Tóth BI. Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk. Front Pharmacol 2022;13:745658. [DOI: 10.3389/fphar.2022.745658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Fiorucci S, Distrutti E, Carino A, Zampella A, Biagioli M. Bile acids and their receptors in metabolic disorders. Prog Lipid Res 2021;82:101094. [PMID: 33636214 DOI: 10.1016/j.plipres.2021.101094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
37 Kiriyama Y, Nochi H. Physiological Role of Bile Acids Modified by the Gut Microbiome. Microorganisms 2021;10:68. [PMID: 35056517 DOI: 10.3390/microorganisms10010068] [Reference Citation Analysis]
38 Zhu Y, Xu S, Lu Y, Wei Y, Yao B, Guo F, Zheng X, Wang Y, He Y, Jin L, Li Y. Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD. Front Pharmacol 2020;11:590. [PMID: 32477115 DOI: 10.3389/fphar.2020.00590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Gui L, Wu Q, Hu Y, Zeng W, Tan X, Zhu P, Li X, Yang L, Jia W, Liu C, Lan K. Compensatory Transition of Bile Acid Metabolism from Fecal Disposition of Secondary Bile Acids to Urinary Excretion of Primary Bile Acids Underlies Rifampicin-Induced Cholestasis in Beagle Dogs. ACS Pharmacol Transl Sci 2021;4:1001-13. [PMID: 33860216 DOI: 10.1021/acsptsci.1c00052] [Reference Citation Analysis]
40 Guo CJ, Grabinski NS, Liu Q. Peripheral Mechanisms of Itch. J Invest Dermatol 2022;142:31-41. [PMID: 34838258 DOI: 10.1016/j.jid.2021.10.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Yu H, Zhao T, Liu S, Wu Q, Johnson O, Wu Z, Zhuang Z, Shi Y, Peng L, He R, Yang Y, Sun J, Wang X, Xu H, Zeng Z, Zou P, Lei X, Luo W, Li Y. MRGPRX4 is a bile acid receptor for human cholestatic itch. Elife 2019;8:e48431. [PMID: 31500698 DOI: 10.7554/eLife.48431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
42 Bolanos CG, Pham NM, Mair RD, Meyer TW, Sirich TL. Metabolomic analysis of uremic pruritus in patients on hemodialysis. PLoS One 2021;16:e0246765. [PMID: 33577623 DOI: 10.1371/journal.pone.0246765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]